Virtu Financial’s Puma Biotechnology PBYI Stock Holding History

Virtu Financial’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-31,477	Closed	-$93K	–	1905
2025 Q1	$93K	Buy	+31,477	New	+$98.5K	0.01%	933
2024 Q4	–	Sell	-26,509	Closed	-$68K	–	1920
2024 Q3	$68K	Buy	+26,509	New	+$80.2K	﹤0.01%	965
2023 Q4	–	Sell	-14,262	Closed	-$38K	–	1897
2023 Q3	$38K	Buy	+14,262	New	+$48.6K	﹤0.01%	933
2023 Q1	–	Sell	-49,760	Closed	-$210K	–	1952
2022 Q4	$210K	Buy	+49,760	New	+$172K	0.03%	680
2021 Q3	–	Sell	-20,384	Closed	-$187K	–	1845
2021 Q2	$187K	Buy	+20,384	New	+$207K	0.02%	1024
2021 Q1	–	Sell	-16,213	Closed	-$166K	–	1913
2020 Q4	$166K	Buy	+16,213	New	+$164K	0.02%	921
2019 Q4	–	Sell	-10,637	Closed	-$115K	–	1736
2019 Q3	$115K	Buy	+10,637	New	+$115K	0.01%	1063
2019 Q1	–	Sell	-17,065	Closed	-$347K	–	1731
2018 Q4	$347K	Buy	+17,065	New	+$512K	0.02%	653
2017 Q4	–	Sell	-5,519	Closed	-$661K	–	2823
2017 Q3	$661K	Buy	+5,519	New	+$513K	0.03%	694

Other funds holding PBYI

ACA

Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Virtu Financial's PBYI Position: Q2 2025 in Review

Virtu Financial sold out of Puma Biotechnology (PBYI) in Q2 2025, closing a stake of 31,477 shares — an estimated $93K sold.

Virtu Financial first reported a position in PBYI in Q3 2017 and held it in 9 quarters. The position peaked at $661K in Q3 2017. 121 funds tracked by Wall St. Rank hold PBYI as of Q2 2025.

Virtu Financial reported no remaining Puma Biotechnology position as of Q2 2025 after selling out during the quarter.
Virtu Financial sold 31,477 Puma Biotechnology shares in Q2 2025, an estimated $93K.
Virtu Financial first reported a position in Puma Biotechnology in Q3 2017 and held it in 9 quarters.
Virtu Financial's Puma Biotechnology position peaked at $661K in Q3 2017.
121 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2025.

Based on Virtu Financial's 13F filing for Q2 2025, filed 12 Aug 2025.